Isabel Trias

1.3k citations
46 papers · 747 indexed · h-index 15

Isabel Trias

45 papers receiving 725 citations

Peers

Isabel Trias
Comparison fields: 5 of 57
  • Urology 89
  • Pulmonary and Respiratory Medicine 337
  • Surgery 356
  • Rheumatology 98
  • Oncology 177
Replace Özden Tulunay with:
Özden Tulunay Türkiye
Hillary Ross United States
Markus Falk Germany
Afaf Amarti Morocco
Aydin Pooli United States
William L. Thelmo United States
Jeffrey H. Reese United States
H Sugao Japan
Milan Vošmik Czechia
H. Mildenberger Germany
Isabel Trias relative to Özden Tulunay Türkiye Özden Tulunay's profile →
Citations per field
00.5×4.3×
Özden Tulunay · 1×
Citations per year

Countries citing papers authored by Isabel Trias

Since Specialization
Citations

This map shows the geographic impact of Isabel Trias's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabel Trias with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabel Trias more than expected).

Fields of papers citing papers by Isabel Trias

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabel Trias. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabel Trias. The network helps show where Isabel Trias may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Isabel Trias, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Isabel Trias Line = papers co-authored together Isabel Trias links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20251
3 20230
4 20183
5 20145
6 201316
7 20134
8 201018
9 200745
10 20066
11 2005143
12 200548
13 20055
14 200337
15 199837
16 19965
17 199512
18 199410
19 19914
20 19896

About Isabel Trias

Isabel Trias is a scholar working on Urology, Pulmonary and Respiratory Medicine, Cancer Research, Rheumatology and Oncology, having authored 46 papers that have together received 747 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (10 papers), Urologic and reproductive health conditions (9 papers), Prostate Cancer Treatment and Research (9 papers), Bladder and Urothelial Cancer Treatments (8 papers), Renal and related cancers (8 papers), Prostate Cancer Diagnosis and Treatment (8 papers), Urinary and Genital Oncology Studies (8 papers) and Cancer Genomics and Diagnostics (7 papers). The work is most often cited by research in Urology (89 citations), Pulmonary and Respiratory Medicine (337 citations), Surgery (356 citations), Rheumatology (98 citations) and Oncology (177 citations). Isabel Trias has collaborated with scholars based in Spain, Netherlands and Italy. Frequent co-authors include Ferrán Algaba, Carles X. Raventós, Ignacio Español, Anna Orsola, Lluís Cecchini, Danieli B. Salinas, Marina Scarpelli, Intan P.E.D. Kümmerlin, Hendrik Van Poppel and Ziya Kırkalı. Their work appears in journals such as European Urology, Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin, Cancer, International Journal of Molecular Sciences and Cancers.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026